Bailes new ASCO Foundation chair

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 10
Volume 16
Issue 10

Bailes new ASCO Foundation chair

ALEXANDRIA, Virginia—Joseph Bailes, MD, editor of Cancer Care & Economics, has been named the new chair of the board of directors of The ASCO Foundation, which works with ASCO to raise and distribute funds for programs that improve cancer care and create an environment for prevention and cure.

A former president of ASCO from 1999 to 2000, Dr. Bailes is a nationally recognized leader in cancer public policy and will continue to serve as co-chair of the ASCO Government Relations Council.

"This is an exciting time in the field of clinical oncology as cancer research and treatments continue to progress, and we are helping to improve the lives of those living with cancer," Dr. Bailes said. "Working with The ASCO Foundation's remarkable staff and board of directors is a wonderful opportunity, and I look forward to supporting continued advancement in the field of oncology in my new role as chair."

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content